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Article
Persons with newly acquired HIV infections experience 
very high viral loads in the first 2 months following expo-
sure, and are relatively much more infectious during this 
acute HIV infection (AHI) period (Cohen, Shaw, 
McMichael, & Haynes, 2011; Gilbert et al., 2013; Pilcher 
et al., 2007). Although estimates of the proportion of new 
infections attributed to AHI vary widely, this might 
approach 50% (Brenner et al., 2007; Cohen et al., 2011; 
Powers et al., 2011). Unfortunately, current standard HIV 
testing approaches rely on the presence of sufficient anti-
bodies to the virus, an immunological process that takes 
between 3 and 4 weeks, before showing a positive result 
(Cohen, Gay, Busch, & Hecht, 2010). As such, although 
individuals might test negative during this HIV antibody 
window period, they could in fact have AHI. Based on 
these test results, individuals might engage in sexual 
practices (e.g., condomless anal intercourse) with sexual 
partners assumed to be HIV negative under the assump-
tion that they are themselves HIV negative.
The inability to diagnose very recently acquired HIV 
infections, and concern about onward transmission dur-
ing this period (Brenner et al., 2007; Cohen et al., 2011; 
Powers et al., 2011), has prompted the expanded develop-
ment and use of novel HIV testing technologies (Yerly & 
Hirschel, 2012). In the Canadian context, pooled nucleic 
acid amplification testing (NAAT) technologies, capable 
of identifying persons with AHI in clinical settings prior 
to the appearance of detectable HIV antibodies, are cur-
rently available only in Vancouver (Gilbert et al., 2013).1
New HIV testing technologies reshape what are under-
stood as specific stages of HIV infection, such as AHI, 
and how one knows about periods of heightened trans-
mission risk during the initial phase of infection. 
Diagnosing HIV during this early stage of infection is a 
technologically enabled process of assessment and cate-
gorization. As Rosengarten (2005) put it, “The objects of 
medical science are materialized and delimited by the 
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means by which they are made known” (p. 71). In our 
study we sought to examine new HIV testing technolo-
gies in practice (e.g., the means by which a client is given 
an AHI diagnosis), in clinical settings where HIV tests 
are situated within the spectrum of technologies and net-
works of providers and client users in which they are 
embedded (Epstein, 1996; Timmermans & Berg, 2003).
Although a number of studies outside of Canada have 
demonstrated the successful implementation of new test-
ing protocols to detect AHI, little attention has been given 
to the range of challenges these new testing services have 
posed to clinical practice. These include challenges to 
clinical providers to understand and explain the full 
meaning of these technologies to their clients, and those 
posed to health promoters to successfully mobilize target 
populations to optimally engage these new testing oppor-
tunities soon after the occurrence of risk events.
An important study that attempted to assess the former 
challenge was the National Institute of Mental Health 
(NIMH) Multisite Acute HIV Infection Study, which 
explored the understanding of AHI among 34 individuals 
with a recent diagnosis in six U.S. cities (Remien et al., 
2009). Their in-depth interviews with these individuals 
found a marked lack of awareness of AHI-related retrovi-
ral symptoms and misconceptions regarding AHI testing 
technologies. Our research extends the work of this 
NIMH study to appreciate the lived experiences of gay 
men newly diagnosed with a recent infection in 
Vancouver, British Columbia. We lengthened the follow-
up period and number of in-depth interviews with partici-
pants (as compared with the NIMH study) from 12 weeks 
postdiagnosis to one year and from two interviews to 
four.
The findings presented in this article are situated in the 
context of our larger study. In this research we set out to 
explore the feasibility of using new testing technologies 
to detect very recently acquired infections as a first 
response to event-specific risk, and how this might result 
in enhanced detection and follow up of gay men. We 
chose to focus our study on this population given that the 
majority of new HIV diagnoses in Canada are among gay 
men and other homosexually active men—a group that 
has been disproportionately affected by the epidemic 
since its onset (British Columbia Centre for Disease 
Control [BCCDC], 2012; Grace et al., 2014; Hogg et al., 
2012; Public Health Agency of Canada [PHAC], 2010). 
Overall, gay men have demonstrated high levels of HIV 
testing in British Columbia. The high rates of HIV inci-
dence in Vancouver among this population offered oppor-
tunities for targeted testing approaches.
Although much HIV research remains dominated by 
quantitative methods such as cross-sectional population 
surveys, Dowsett (2007) rightly pointed out that in the 
field of gay men’s health research, “the advent of the 
human immunodeficiency virus (HIV) epidemics in 
many parts of the world proved a significant stimulus in 
calling forth qualitative methodology to assist in compre-
hending one of the most complicated public health prob-
lems of the modern period” (p. 420). The qualitative data 
we drew on in this analysis elucidated the dialectic of a 
new HIV technology in practice (Timmermans & Berg, 
2003) by considering how participants’ accounts reveal 
aspects of the relationship between advances in HIV 
diagnostic technologies and the users of these medical 
technologies (e.g., clients and providers). Gay men’s 
accounts of their everyday lived experiences provided us 
with “entry” into processes of social coordination (Grace, 
2013b; McCoy, 2005).
Although the focus of our analysis is patient narratives 
of HIV testing technologies “in action” (Latour, 1987), in 
this article we demonstrate the ways in which men’s diag-
nosis experiences speak to how HIV tests must be exam-
ined alongside the “entire gamut of mundane to 
sophisticated technologies, drugs, and even managerial 
instruments such as patient records” (Timmermans & 
Berg, 2003, p. 104). As Timmermans and Berg noted, 
“technologies are embedded in relations of other tools, 
practices, groups, professionals, and patients and it is 
through their location in these heterogeneous networks 
that treatment, or any other action, is possible in health 
care” (p. 104). In our analysis we take into consideration 
that the insights one has regarding one’s diagnosis experi-
ence can illuminate complex matters of social structure 
and institutional coordination (Pierret, 2003). As such, 
we endeavored to move beyond social scientific criticism 
to offer opportunities for the improved implementation of 
diagnostic technologies in everyday clinical practice.
Method
The qualitative narratives drawn on in this analysis were 
collected concurrently with quantitative data as part of 
our longitudinal multiple-methods study design 
(Creswell, 2003). Where relevant, limited demographic 
and behavioral data collected during the baseline quanti-
tative interview are used to describe the sample. In this 
article, we focus on the qualitative data collected at the 
first interview that related to men’s discovery and diagno-
sis of an acute or recent HIV infection.
Procedure
Gay, bisexual, and other homosexually active men diag-
nosed with acute or recent HIV infection during the 
period April 2009 to June 2012 were offered entry into a 
Canadian Institutes of Health Research (CIHR) Study of 
Acute HIV Infection in Gay Men.2 AHI cases were 
defined as those in which HIV RNA was detected using 
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NAAT in the absence of confirmed detection of HIV anti-
body (Gilbert et al., 2013). Recent cases were defined as 
those with a confirmed detection of HIV antibody and a 
negative HIV test during the previous 12 months. All 
study participants had to meet the following additional 
criteria: (a) self-disclose having sex with men (includes 
gay, bisexual men, and other men who have sex with 
men) at the time of their HIV test; (b) aged 19 years or 
older; (c) speak English; and (d) able to fully comprehend 
the study consent form. Participants were provided an 
honorarium of $25CDN for each study component they 
completed (i.e., both the quantitative surveys and qualita-
tive interviews). Ethics approval for this study was 
obtained from the University of British Columbia 
Research Ethics Board.
Participants
In total, 25 HIV-positive men took part in this study. At 
the time of enrollment, the majority of participants were 
older than 30 years (80%), with the mean age being 39 
years. Most men lived in Vancouver (79%) and self-iden-
tified as gay (96%), leading us to use this category to 
describe the sample of men interviewed.3 The majority of 
participants were employed full time (64%); however, 
there was considerable diversity among those who were 
not (e.g., disability, student, unemployed). Most men 
reported completing college or university (64%), and the 
mean income was between $30,001CDN and 
$50,000CDN. Participants identified as White (72%); 
Asian (12%); Hispanic (8%); Aboriginal, First Nations, 
Metis, or Inuit (4%); and African/Black (4%).
Data Collection
Interviews were conducted by the first and third authors 
in a community sexual health clinic located within a cen-
tral gay area of Vancouver. During the course of inter-
views, interviewers probed further to explore emerging 
information regarding the lived experiences of partici-
pants. Interview guides were developed by the study 
investigators in consultation with community partners. 
Baseline quantitative surveys were administered after a 
median of 35 days postdiagnosis (range 8 to 128 days). 
The first qualitative interview was conducted approxi-
mately 14 days after study enrollment.
In-depth interviews focused on the following key 
domains: diagnosis experiences of newly diagnosed gay 
men; likely site(s) of HIV infection and risk assessment; 
perceived responsibility for HIV prevention and evolu-
tion of HIV views; experiences with the disclosure of 
HIV status, stigma, and social support; sex as an HIV-
positive gay man; life as an HIV-positive gay man, 
including current and perceived future impacts on social 
and sexual life; reasons for seeking or not seeking peer 
counseling; and the self-perceived impacts of research 
participation on study participants. The first two domains 
were the focus of baseline interviews, with the remaining 
domains being explored during three follow-up inter-
views (completed approximately 45 days, 180 days, and 
360 days after enrollment in the study).
Analysis
Qualitative interviews were digitally audiotaped, tran-
scribed verbatim, and reviewed by a research assistant for 
accuracy. The coding approach to this baseline data was 
consistent with thematic analysis (Braun & Clarke, 2006). 
NVivo 8 was used to help manage the interview data and 
explore emergent themes (Bergin, 2011). In the first 
phase of the data analysis we reviewed 10 transcripts as a 
qualitative coding team to familiarize ourselves with the 
dataset, note initial trends and ideas, and create a provi-
sional codebook. These codes were developed from a 
combination of overarching domains in the interview 
guide as well as key themes that emerged during the 
review of transcripts.
In the second phase of analysis, codes were applied to 
the whole dataset and refined as needed. At this stage, 
interviews were independently coded by two persons 
from an interdisciplinary team of researchers, including a 
PhD-level sociologist, MPH-level researcher, MD-level 
epidemiologist, and the study coordinator, who has expe-
rience in public health and community-based research 
with gay men. Codes were compared across interviews 
and the qualitative analysis team reviewed coding dis-
crepancies until consensus was reached (Creswell, 2003; 
Mason, 2005). Memos were recorded throughout the 
iterative process of coding to capture analytic insights 
about emerging themes and relationships across the 
narratives.
It is important to note that the earliest study partici-
pants were among the first people to receive NAAT tests 
in Vancouver because this technology was implemented 
concurrently with the first phase of participant enroll-
ment. Client experiences, including those of study par-
ticipants, were used iteratively to improve provider 
education and clinical practices over the course of the 
study.
Findings
Experiences of HIV Testing and Learning of 
One’s Diagnosis
In this first section of the results we discuss three related 
themes that emerged across the narratives of men with an 
acute or recent infection (N = 25): (a) testing rationale and 
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expectation of results; (b) delivery of results over the tele-
phone (officially and unofficially); and (c) diagnosis in clini-
cal settings. Among other important insights, men’s narratives 
reveal the ways in which their experiences of learning of their 
HIV test results were embedded in social relations of other 
technologies such as past HIV testing experiences and the 
practices and processes used to manage patient records and 
regulate the disclosure of positive test results.
Testing rationale and expectation of results. The most com-
mon reasons for testing noted by men in this sample 
included one or more of the following: 48% reported a 
recent sexual encounter perceived to be risky (e.g., having 
unprotected, condomless anal intercourse with an 
unknown status or HIV-positive partner; the condom 
broke or came off); 40% reported experiencing symptoms 
of seroconversion illness (a flu-like illness commonly 
associated with very recently acquired HIV infection); 
32% said they engaged in testing as part of their routine 
testing activity. Other common reasons reported for HIV 
testing included being recommended for testing by their 
doctor because it had been a long time since their last test 
(16%) and starting a new relationship (12%). This sample 
was composed of men with diverse expectations and ratio-
nales regarding what their test results would indicate (44% 
expecting a negative test result, 36% a positive test result, 
and 20% noting that they were not sure).
A combination of knowing a partner was HIV-positive 
and the experience of flu-like symptoms led a number of 
men to say they expected a positive test result. One man 
expressed that these “two ideas together equaled a pretty 
safe assumption.” For participants who were diagnosed 
in the acute period and experienced seroconversion ill-
ness, these symptoms frequently were reported as their 
reasons for getting tested for HIV and informed what they 
expected their results to be. For example, one participant 
described that his experience of seroconversion symp-
toms meant that he was quite sure of his HIV-positive 
status prior to receiving his diagnosis:
However, at the same time that I was going back to get 
tested, I felt super sick, and I never felt like, that sick in my 
life. I had a high fever and I could barely move. And so I got 
tested at the same moment that I was probably 
seroconverting.…I think that’s why I knew before I got the 
results, that, you know, this was not just a flu. And I had read 
about it because obviously I was very concerned about it, so 
I read a lot of information on the Internet on how it happened. 
And when I got that flu, and then I was so sick, I barely 
moved; and actually I went to [hospital] because I was 
burning fever. And I just knew that that was it.
Those participants who said that they tested for HIV as 
part of their routine testing most frequently talked about 
the expectation of negative test results. Some men who 
described this testing rationale articulated that past expe-
riences with receiving HIV-negative test results informed 
the expectations they had at the time of diagnosis:
Well, I’ve been doing the HIV testing for the last eighteen 
years. Yeah, eighteen years, and I do it twice a year. And I 
always do it as a precautionary thing. And after eighteen 
times two, thirty-six results, I got used to the idea that it’s 
going to be negative every time, right?
These narratives reveal that about half of the men 
interviewed received a positive diagnosis they were not 
expecting. Unlike men anticipating they would be given a 
positive diagnosis, many of these men reported that they 
did not perceive themselves to be “at risk” of HIV infec-
tion and/or they “got used to the idea” that test results 
would always be negative.
Delivery of results over the telephone. Most participants 
said that they were officially told of their test result in a 
clinical setting; however, a number of men reported being 
told of their HIV-positive status over the phone while 
they were at work, at home alone, with a partner, or with 
family. Many of these men indicated that receiving a 
phone call from a clinic or their physician’s office, or 
simply seeing the clinic name come up on their caller ID 
(identification), either confirmed their expectation of an 
HIV-positive test result or was enough to reveal their sta-
tus, even if they did not have prior concerns.
One participant discussed receiving a voicemail mes-
sage from the clinic while on vacation, asking him to call 
back. The participant reported that he returned this call 
and was asked to visit the clinic to provide another blood 
sample. Although he was not given his test result over the 
phone, he explained that the phone call signaled some-
thing was definitely wrong: “But at that moment I knew 
something was wrong.…I said, like, you know what? I 
think I’m positive. Most likely.” Despite this initial suspi-
cion, the participant described that he remained uncertain 
regarding the meaning of the phone call. He said he later 
came to reason through talking with his partner, with 
whom he continued to have condomless anal sex, that he 
would have been told he was HIV positive when talking 
to clinic staff if this had in fact been the case.
For another participant, his HIV-positive test result 
was given to him over the phone while he was at work:
They said it wasn’t common practice to give numbers out to 
get results. But she had given me hers, and she told me to 
call on the particular day.…So I did call to get my results, so 
I didn’t have to go back there again.
The participant said that he had expected the test results 
to be negative—“I hadn’t done anything different prior to 
any other test, like, I was always using condoms”—and 
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went on to describe the process of getting his HIV-positive 
diagnosis over the phone from another nurse, who read off 
the results from a form:
He read off the list of, “Okay, negative, negative, negative, 
negative.” And then the last one was, “HIV positive.” He 
said, “You’re positive for HIV.” And at that point it was, like, 
everything just went [makes noise like an explosion], like, 
just kind of blank. I was there for…I was in the supply room, 
and I had to go back to the front desk and do my job.
For this participant, receiving his results in this way cre-
ated a difficult situation for him at work. He had to deal 
with the emotional reaction of learning of his HIV status 
while not wanting to disclose this information to col-
leagues. He also was not able to take advantage of the 
immediate support offered by the health care professional 
who provided his diagnosis.
In another instance, one man explained that although 
he had an extreme aversion to receiving his test results 
over the phone, a delay in processing his test meant that 
he was unable to talk with someone in person:
I was told that the [HIV] results would be back in seven 
days, or something like that. In reality, they weren’t back in 
seven days. They actually were back in eight days. So when 
I went back in seven days and the results weren’t in, that was 
the worst thing that could have ever happened to me, because 
I had to wait another twenty-four hours. So I, for me, that 
was a huge thing. It was, like, you know, I worked my way 
up to going in. I didn’t definitely want to hear it over the 
phone; I wanted to go in first face to face, and turns out it 
wasn’t there. So what I’d have to do the next day is they 
called me on the phone.
Finally, one participant’s experience with discovering 
his positive HIV status over the phone led him to develop 
a strong opinion that the current system for delivering 
results should be reviewed to standardize the delivery of 
results:
So it’s kind of ridiculous that you say, “Oh, I cannot tell you 
on the phone,” yet I told you before that “I will only be 
calling you if there was something wrong, right?”…But I 
think it’s a lot better that you tell people [that] either way 
we’ll call you, right? I mean, if things are good, we’ll call 
you. If things are bad, we’ll call you.
Delivery of results in clinical settings. Men also highlighted 
the experience of officially learning of their HIV test 
results and interacting with health care providers in a 
clinical setting at the time of diagnosis. Learning of their 
results produced varying feelings for participants, includ-
ing the alleviation of uncertainty. For one participant who 
had been very ill prior to diagnosis, relief was the main 
factor in his initial reaction:
In a way, I felt relieved, because at least I knew and at least 
the uncertainty was over. So now there was like, a game plan 
we could follow to get on with my life. For the record, two 
weeks before that, when I was waiting for results, it was like, 
you’re kind of in a state of limbo, not knowing what’s 
happening with your life. And, I mean, it may sound kind of 
flippant, but I don’t worry about getting HIV any more. It’s 
one less stressor in my life.
Overall, participants noted feeling extremely well sup-
ported by the professionals who gave them their test 
results, and believed they were offered adequate support 
services at the time of diagnosis in a health care setting: 
“I was treated with a lot of respect, with a lot of love and 
a lot of compassion. I think compassion is a main word. 
So, no, I would say I wouldn’t change anything.” When 
considering the professional who gave him his test result, 
another man said,
I identified with him; we were kind of cut from the same 
cloth. There was a lot of understanding. I already knew a lot 
of information.…He was very helpful, yeah. He was 
awesome for that kind of an experience.
That being said, a few participants reflected on possi-
ble areas for improvement in their clinical experience. 
For example, two participants reported learning of their 
results indirectly, rather than through communication 
from a clinician (e.g., seeing their positive test result dis-
played on a computer screen in the clinic room).
Making Sense of an Acute Diagnosis
Participants who received an acute diagnosis (n = 13) 
reflected on how they felt when they were told they were 
in the acute phase of HIV infection, and the extent to 
which this additional information informed their diagno-
sis experience, including their reaction to being HIV pos-
itive. Analysis of men’s narratives of the “acute” impact 
on their experience of initially learning of their diagnosis 
revealed five interconnected themes: (a) initial provider 
and patient uncertainty about HIV test results; (b) uncer-
tainty about the meaning of acute infection; (c) relation-
ship to starting treatment; (d) relationship to having sex; 
and (e) relationship to identity formation as an HIV-
positive man.
Initial provider and patient uncertainty about HIV test 
results. Participants who were in the acute phase of infec-
tion at the time of diagnosis shared their perception that 
the new “early” testing technology created varying 
degrees of uncertainty for providers regarding the initial 
interpretation of their HIV test results. When first dis-
cussing their HIV test results, some men recounted that 
their health care providers seemed “uncertain” or 
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“unclear” about how to interpret results they had been 
given, both at the time of diagnosis and during other test-
ing procedures. Many participants noted that this uncer-
tainty as to their HIV status increased their anxiety around 
the diagnosis experience and their own understanding of 
their HIV test result.
For example, one participant recounted that his doctor 
initially found the HIV test results confusing, and then 
assured him it was likely to be a false positive. The par-
ticipant said his doctor later requested additional testing:
Everything was good until he got to the HIV test and he 
looked very puzzled because the results were confusing or 
conflicting, and the results came back negative. However, 
there was uh, one other, blood screen test which is very new, 
was the early detection. [It] showed the presence of 
antibodies, so, he didn’t seem too concerned about it, um, 
and I wasn’t either ’cause he was saying that there, you 
know, could be false [positive] and, and um, possibly people 
that have, um, arthritis or inflammatory problems like I do, 
um, that there could, pose false [positives], or, or whatever. 
So, um, left the office that day. And uh, I didn’t really not, 
really too concerned about it. But then I got a phone call 
from him…and he said that there was the possibility of an 
early infection. That he wanted me to do more blood work, 
uh, the next day. Uh, so I was very concerned and very upset 
at that point. Uh, confused and uh, didn’t know what to make 
of it.
The same participant went on to report his impression 
that his health providers did not have enough information 
to interpret his test results, and that he received conflict-
ing information about his HIV status:
I don’t think they know enough about the, that the ability to 
test it, [if] there’s been a recent infection. Um, when I went 
in that same time, I had to have some inoculations done and 
the nurse there went over my blood work results and he, uh, 
asked me how long have I been on meds [medications]. And 
I said, “Well, I haven’t been on meds.” And he said, “Well, 
that’s unusual, because your blood work shows that you’re 
undetectable and your CD4 is normal.” And I said, “Well, 
you know….” He was puzzled and then he said it “was bull, 
maybe it’s not really an infection.” And, and, so again you 
have this whole confusion as to “What am I?” you know, 
“Am I positive or not positive? Am I, have I been exposed to 
the virus and um, it’s just sitting there, or was I exposed a 
long time ago and my body somehow fought it off and 
there’s just antibodies left there?” You know, I didn’t know 
anything. Um, and they didn’t know.…So I’m just sitting 
like a time bomb here, waiting just to find out, when’s this 
thing going to erupt?
In addition to uncertainty among providers, partici-
pants’ understanding of the meaning of receiving a “par-
tial” or “provisional” positive test result varied. One 
participant understood that he had a “partial-positive” 
result from the NAAT test and that there was still the pos-
sibility that it might have been a “false positive”:
That it was only a partial-positive mode, that it may have 
been a false positive was, you know, it made me hope for the 
best but fear for the worst. You expect the worst, but you 
keep praying that it’s a fluke, and that it’s a false positive.…
So in a way, you did, you delayed dealing with reality, I 
think.
Uncertainty about the meaning of acute infection. Different 
participants reported being told about their acute status at 
different points in their care, with some men being noti-
fied immediately at the time of diagnosis and others dis-
cussing this additional information at a later point with 
their primary care provider or not at all. For many partici-
pants, the meaning of acute infection was unclear, with 
some undertaking additional research either prior to diag-
nosis or after receiving their acute diagnosis. That being 
said, following their diagnosis, overall men described 
knowing they were in a period of extremely high viral 
load regardless of their knowledge of acute infection.
Participants who were told about their acute infection 
at diagnosis often noted that they were not able to fully 
“absorb” the information at the time. For example, one 
man explained that although his doctor was thorough and 
patient, at the time of diagnosis, “emotionally, I wasn’t 
able to probably hear.” Another participant said that 
although he did not remember any discussion about acute 
infection at the time of diagnosis, his doctor “may have 
[discussed it] and I just…my mind was elsewhere. But I 
don’t remember him saying it.”
For men who engaged with this information about 
their stage of infection, many reported being unclear 
about the significance of the acute component of their 
HIV diagnosis:
At that point I still wasn’t exactly sure what acutely infected 
meant. I know it’s a high viral load, which means the virus 
was extremely, you know, high. My immune system was 
extremely low, obviously. So I was just worried about 
getting sick with a flu or something.…I was just confused, 
you know. I didn’t really know, understand what exactly my 
stage was, and you know, I was just kind of worried about it. 
But they said that they caught it early enough that they can, 
you know, give me lots of help with it, so, so, yeah.…They 
just mentioned some numbers to me, which didn’t really 
make sense.
Some participants reported seeking information about 
acute HIV infection online, both prior to testing and after 
receiving their acute results. For example, one participant 
noted his partner took on additional research: “He knew a 
lot about, like, since the phone call [when I received my 
diagnosis]. He started researching online.” Another man 
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recounted seeking more information about seroconver-
sion symptoms and the acute phase of infection when he 
was feeling ill:
To be honest, I didn’t even know a lot about the acute phase 
until I was actually feeling sick, and like, “Crap, what the 
fuck is this?” I’m like, “Is this HIV? Is this the acute 
sickness?” And I looked it up, and did all my research.
One participant explained that he first became aware 
of acute HIV infection through a locally organized HIV-
testing advertising campaign—called “Hottest at the 
Start”—led by our community partner, Health Initiative 
for Men (HIM).4 He noted that the campaign informed 
his overall diagnosis experience and might have influ-
enced his decision to get tested months after looking up 
information on the campaign online (Gilbert et al., 2013). 
Because of this prior information, he described assuring 
the nurse at the time of diagnosis that he was knowledge-
able about HIV and did not need her to provide additional 
explanation regarding viral load.
A number of men reported that the terminology of 
“acute” infection was not used when their diagnosis was 
initially relayed to them. In some instances, participants 
discussed that their provider focused on the concept of 
viral load rather than talking about their stage of infection 
in terms of acute status:
No, he didn’t use those terms, “acute,” no. But he basically 
diagnosed it from the moment it started so I am sure we are all 
on the same page here.…Oh, he drew some charts on a paper. 
He had charts and just told me how that, how my level is going 
to be in probably, you know, some people go up to ten million 
in their count, and my rate is going to be up here, and that my 
body is fighting it and eventually, I was there for almost like an 
hour and drawing all the charts, where I am right now and 
where I’m going to be in a month from now. And he’s been 
very accurate. Because what I read the first time it was like a 
two-and-a-half-million count, and today is twenty-two 
thousand, so it’s a huge drop in three weeks or four weeks. So 
the next time he’s predicting it’s going to be a thousand. So he 
said by August it will be zero. So, and I realize he also does a 
lot in his field, but he’s been very accurate on his predictions.
Finally, for some men, receiving information about 
their acute or early HIV infection stage at the time of 
diagnosis was described as a welcome “relief” and helped 
to explain symptoms they were currently experiencing or 
had recently experienced:
Being told I was in the acute phase helps explain some 
things, like why my energy levels were lower, why I was 
still, you know, still getting night sweats, why I was feeling 
just kind of run down in general. [It was] because my body 
was working so hard to try and fight off this infection. So 
yeah, having an understanding that, okay, this is normal 
during the early phase has definitely helped putting my mind 
at ease that this isn’t going to be forever, that I sort of have 
to get through this initial stage.
Relationship to starting treatment. Among participants 
who engaged treatment shortly after diagnosis, being in 
the acute phase of HIV infection was articulated as a 
major motivating factor for this decision. Men described 
that their health care providers often initiated treatment in 
the context of needing to “bring down” high viral loads. 
As such, participants understood that the positive signifi-
cance of receiving their diagnosis during the acute phase 
was related to how fast they could start treatment and, in 
some cases, become “undetectable.”
Many participants who had already started treatment at 
the time of their first interview noted that it was “reward-
ing” to see their viral loads—which initially were very 
high—fall after beginning medication. Men’s narratives 
reveal the ways in which HIV testing was one part of an 
overall and ongoing diagnosis experience, which included 
discussions of viral load measurements, including having 
an undetectable viral load following optimal antiretroviral 
treatment and the functioning of their immune system, as 
measured by the number of CD4 white blood cells:
Oh, well, see, remember that I didn’t hear how incredible 
high my viral load was when I was sick until I was starting 
to feel way better and my viral load had been reduced many, 
many, many times, to the thousands. You know, knowing 
that I had that big improvement, the fact that at that point I 
had now found out how horribly high it was when I was sick, 
it was a shock, but I mean, it didn’t change my attitude with 
being HIV positive. It made me think, “Okay, these drugs 
really work,” so that was a good thing. But it wasn’t about 
the HIV; it was about the drug: “Oh, my God, these drugs are 
amazing. Look what they’ve done in two and a half weeks!”
I never knew what my test results were until I actually was 
told. Right? And that I was going to go on medication. So, you 
know, some people, I don’t know. I don’t know what the 
decision was, or why, what the decision was to put me on 
medication immediately. I think it was because my counts 
went so high, and my CD4s dropped so low, whether they 
thought they were going to come back up or not, but they just 
decided to, say, “Go on it right away.” And, I mean, you know, 
the way that I am right now, I’m undetectable, and my CD4s 
are up, at this point. I expect to find them somewhere between 
three hundred and fifty and four hundred and fifty at this 
point. You know, from a low of two hundred and fifty, when 
they took the first one. But they were already up at three 
hundred and fifty by the time I got my second test results, after 
a month on the medication, three weeks on the medication, so.
In these examples, new technologies of “early” testing 
interacted with existing technologies and knowledge of 
viral load and treatment to impact participants’ 
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experience of their diagnosis and decisions about ongo-
ing care.
In a related narrative, one man explained that his health 
care provider described the benefits of detecting HIV early 
in terms of both dropping his viral load and having optimal 
flexibility about accessing future treatment options:
What the doctor tried to do is, he tried to explain it in a very 
positive way, in the sense that, “Because we caught this so 
early, there is a much greater chance of shutting the virus 
down quickly, or quicker.” And potentially down the road, 
because I was diagnosed so early or so quickly, there might 
be potential treatments that others may not have the option 
of taking. So, from that perspective, I thought, “Okay, well, 
you know, there might be a little more hope now than if I’d 
found out six months later.”
For many participants, an acute HIV diagnosis 
impacted their decisions around treatment. They identi-
fied medical benefits, as explained by their health care 
providers, of early diagnosis and treatment debut. Some 
also described that treatment decisions were motivated by 
concerns regarding onward transmission during this ini-
tial phase of infection; for these men, wanting to have sex 
and minimize risk to their partner motivated the decision 
to start treatment promptly.
Relationship to having sex. Nearly all participants described 
an initial period of refraining from sexual activity following 
their HIV diagnosis, although the length of time varied. In 
many cases, participants explained that providers initiated 
conversations about reducing sexual activity; however, a 
majority of participants explained that they undertook to 
reduce sexual activity themselves as a result of high viral 
loads and concerns with onward transmission.
Many participants described that at the time of diagno-
sis, their nurse or doctor explained the significance of the 
acute diagnosis in relation to the need to be cautious 
when engaging in any sexual activity:
She [nurse] said, “You are acute, like, so you’re highly 
contagious. Highly, highly contagious.” So, she was like, 
“For everyone’s health, it would be good if you just, like, 
take it easy for a little bit.”…At first I felt like, “Okay, I’m 
not having sex till I have this phase of being acute.” That’s 
my first thought. It was like, “Okay, I’m not having sex at 
all.” But I don’t know. Like, right now, it’s just, like, I mean, 
after a few weeks, well, it’s not that I’m bad, it’s not that I’m 
not going to have sex ever again, so, like, well, I’m just 
going to live my life. I just need to be careful. And that’s how 
I feel right now.
The nurse said, “So you’re super, super infectious right now. 
Your viral load is up eight hundred thousand. You are in an 
extreme [situation].” Oh, yeah. So, in fact, that was part of 
my confirming. The nurse told me, you know, “You’re really 
infective, so to abstain, so for now, it’d be best to abstain 
until your viral load comes down.”
For some participants, this concern about being hyper-
infectious resonated very strongly: One participant said, 
“Well, it definitely made me terrified of having sex at all, 
because I know how infectious one is in that early stage. 
So it just definitely, just made me completely step back 
from sex for a while.” Another man talked about this in 
relation to becoming “undetectable”:
I want to be undetectable. Like I said, I don’t want to put 
anyone else in danger. So, being undetectable is important. But 
I am nervous.…A little nervous about the side effects…I also 
want to be undetectable. Because I truly feel that if I am 
undetectable, I have a very slim chance of passing on the virus.
One man noted that being diagnosed in the acute phase 
did not have much of an impact on his sexual behaviors 
because his sex life was not a major focus for him at the 
time, and he was not planning on having much, if any sex 
in the upcoming months:
Not really, because my sex life was, or still is, kind of on the 
down-low part of my life. I have other things I need to focus 
on. So, being in the acute phase was not a very prominent, 
important thing in my life, at the time. However, the positive 
result, or knowing that I had seroconversion, did have an 
impact on whether I wanted to have sex or not. So, the acute 
phase may be part of that as well.
Another participant reported that he felt he would be 
more comfortable telling his former sexual partners he 
had seroconverted once his viral load was “undetectable,” 
given the sexual nature of their relationship:
Participant (P): Well, knowing that my viral load came from 
two and one-half million down to twenty-two thousand 
in three weeks, I find that very consoling, you know.
Interviewer (I): Yes.
P: So I wouldn’t even, I have this one ongoing f-buddy [sex-
ual partner], and he keeps phoning and emailing me, but 
there’s no way I would even consider having sex with 
him. You know—knowing my HIV count was so high. 
But knowing now that it’s getting basically down to that, 
you know, it makes it that much more okay. You know?
I: Okay.
P: Because there’s no way I would have entertained doing 
anything with anybody with two million. You know, so.
I: Right.
P: That’s respect for myself and respect for others, too, you 
know?
I: Right. Okay. So it might be easier to talk to at least some 
of these guys that you have sexual relationships with 
about being [HIV] positive after you find out that you 
have an undetectable viral load?
P: Exactly. If they’ll believe that to be true.
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Finally, many participants noted that knowledge of 
being in the acute phase of infection provided them with 
insights about their likely HIV infection event. 
Participant’s retrospective accounts of the event or events 
that they believed might have led to their seroconversion 
reveal diverse experiences and understandings of HIV 
transmission risk. These infection-event attributions are 
the subject of a forthcoming analysis.
Relationship to identity formation as an HIV-positive man. For 
most participants, their acute diagnosis had very little 
impact on the ways in which they reported viewing them-
selves as HIV-positive men, and few made a distinction 
between receiving an acute diagnosis and a learning of 
their HIV-positive status more generally. For example, 
some participants described thinking about how they 
would have reacted to someone who was HIV positive 
and “undetectable” prior to their diagnosis:
I don’t know. Before, when I was negative, being positive is 
positive. Either [they’re] acute or they’re not acute. Many 
people don’t know about this phase, so it’s just the fact that 
you are positive. Like, I don’t know, before, if somebody 
said, like, “Okay, I’m positive, but my viral load is 
undetectable,” or someone is, like, “Oh, I’m positive but my 
viral load is half a million,” to me, you’re positive. Period.
Another man explained: “I really don’t know the dif-
ference. I, I’m HIV positive. But, am I any different from 
my friend who’s HIV positive from thirteen years ago? 
And I can still transmit the disease. You know, where, 
what’s the difference?” Many participants described 
thinking that “HIV is HIV” or “positive is positive,” and 
noted the lack of significance of the acute diagnosis in 
their overall thinking of themselves as HIV-positive men.
Discussion
Technological innovations in the scope of medical prac-
tice have led to ontological and epistemological transfor-
mations of HIV (Mol, 2002; Timmermans & Buchbinder, 
2011). Our findings suggest that the integration of new 
HIV testing technologies to diagnose HIV soon after 
infection, and before it can be detected by standard testing 
protocols, demands additional reflection regarding the 
institutional processes for providing test results and the 
challenges of interpreting the meaning of new diagnostic 
technologies (e.g., NAAT) and illness categories (e.g., 
acute HIV infection) for providers and patients alike.
As Pilcher, Christopoulos, and Golden (2010) argued, 
“Acute HIV infection detection adds a new and poten-
tially powerful tool to the prevention armamentarium” (p. 
S9). The prevention premise for the use of NAAT to com-
plement antibody-based HIV testing is based on the 
understanding that knowledge of HIV-positive status 
typically leads to reduced risk of transmission (Marks, 
Crepaz, Senterfitt, & Janssen, 2005); for example, emerg-
ing evidence from studies that have focused on persons 
with very recently acquired infections suggest that these 
individuals are likely to reduce high-risk behavior after 
being informed about their serostatus (Fox et al., 2009; 
Steward et al., 2009; Vallabhaneni et al., 2013).
In addition, early diagnosis provides clinical opportu-
nities: for immediate identification of a patient’s HIV sta-
tus; for timely interventions such as acute-stage 
prevention counseling; for outreach to recent sexual part-
ners; and for early enrollment into antiretroviral treat-
ment programs that can lower viral loads and 
infectiousness (Hogg et al., 2012). These initiatives might 
assist those who engage in high-risk behaviors from fur-
ther transmitting HIV and/or acquiring other sexually 
transmitted infections postdiagnosis (Crepaz et al., 2009; 
Gorbach, Drumright, Daar, & Little , 2006).
Acute HIV infection is an important public health con-
cern. The rationale for the expedient delivery of test 
results and the use of new HIV testing technologies is 
clear from a public health perspective. Acute HIV infec-
tion calls on public health programs to respond in a timely 
fashion because of the increased probability of onward 
transmission as a result of very high viral loads. These 
opportunities for intervention are afforded by the avail-
ability of pooled NAAT and the subsequent diagnostic 
category, “acute HIV infection.” However, the public 
health goal of reducing onward transmission needs to 
retain the complementary goals of providing psychoso-
cial and medical support when delivering a positive test 
result, and is reliant on the successful use and interpreta-
tion of diagnostic technologies.
Learning of one’s HIV status is a process of discovery 
that is experienced differentially, and often over a period 
of time. Participants made evident that coming to know 
of their HIV-positive status was often not a single clinical 
event but involved a process of ascribing meaning and 
connecting a range of factors such as biological symp-
toms, self-assessments of past risk behaviors, and 
“unusual” institutional practices (e.g., a phone call from a 
doctor; being asked to come to the office for test results). 
However, the significance attributed to such phone calls 
and requests to visit the clinic for results differed for par-
ticipants. As such, this data has implications for clinical 
and public health practices, including how and when peo-
ple are given their HIV diagnosis.
Delivering HIV test results is important work, and it is 
not without challenges. Although many of the partici-
pants described being well supported, their narratives 
also illuminate potential institutional failures that can 
arise in the process of giving an HIV-positive diagnosis. 
Men’s experiences raise questions concerning the 
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circumstances under which disclosure of HIV status 
should happen over the phone. Although we have high-
lighted the possible dangers of giving results over the 
phone (both officially and unofficially in some cases), we 
have also considered the institutional consequences of 
not giving results over the phone, which are particularly 
significant in cases where there are heightened public 
health risks, such as with acute infection. It is important 
to note that client demand for the delivery of test results 
over the phone led, in part, to this relatively recent shift in 
institutional process.
It is clear from this sample that many men understood 
the significance of their acute infection in relation to ini-
tiating early antiretroviral therapy to hasten viral load 
decline during the acute-infection stage. This insight 
demonstrates the need to consider the relationship 
between diagnostic technologies for early testing and 
when biomedical technologies, such as antiretroviral 
therapy, are given for early treatment. From the perspec-
tives shared by many participants, talking with health 
care providers led them to understand that the use of the 
diagnostic technology was significant because it enabled 
the timely delivery of the treatment technology. These 
narratives relate to sociological research literature that 
explicates the importance of positive doctor–patient rela-
tionships in facilitating clear explanations of medical pro-
cesses (McCoy, 2005).
Our findings point to considerations for public health 
programs that elect to use new HIV testing technologies 
such as NAAT. The first speaks to the need for additional 
provider education about the virological and immuno-
logical response to infection in the first few months fol-
lowing exposure, and the relation of testing technologies 
to these responses. Education needs to include clear 
guidelines for communicating the results of various test-
ing approaches, including meanings associated with anti-
body, antigen, and viral genetic material identification, as 
well as the related concepts of infectiousness and onward 
transmission to patients. Opportunities for providers to 
practice explaining these concepts to patients might prove 
beneficial.
Some patients are not able to take in this detailed 
information at the time of diagnosis. Follow-up appoint-
ments, at which point the significance of their stage of 
infection can be explained in an accessible manner, 
should be considered. Future research might explore 
what types of information would be most useful for newly 
diagnosed men in the AHI phase, as well as the long-term 
impact of provider-led discussions cautioning patients to 
abstain from, or limit, certain types of sex during AHI.
The second consideration involves providing and sup-
porting communication strategies and initiatives to assist 
those individuals seeking information from print- and 
Internet-based resources provided by AIDS service 
organizations and community-based organizations 
regarding seroconversion illness symptoms, viral load, 
and the availability of “early” HIV tests; for example, the 
meaning of acute infection, and the differences between 
“early” and “rapid” tests must be clearly communicated 
to gay men to increase community knowledge regarding 
the window period of heightened transmission risk and to 
support the uptake of these tests. There were a number of 
participants who said that they had knowledge of these 
concepts, and engaged in processes of “self-diagnosis” 
before and/or after being tested for HIV. Their experi-
ences highlight the possible impacts of providing acces-
sible information regarding the diagnostic opportunities 
afforded by technological innovations such as NAAT.
Finally, the third consideration of our findings con-
cerns the need to recognize new psychosocial challenges 
that potentially confront those diagnosed with very 
recently acquired infection. For example, these persons 
might encounter questions about the nature of hyperin-
fectiousness and should be supported in describing what 
might be viewed as a new category or stage of illness to 
significant others. Practitioners must also consider the 
possibility that patients diagnosed earlier will have an 
increased sense of certainty regarding their infection 
event (Grace, 2013a). Our findings support the idea that 
receiving an acute diagnosis does not appear to impact 
men’s overall narratives of incorporating HIV into their 
biography (e.g., noting that “HIV is HIV,” irrespective of 
the stage at which one is diagnosed). However, acute 
infection is made meaningful to patients through conver-
sations with health care providers about sexual practices, 
knowledge of likely infection events, and the early 
accessing of treatment.
New technologies often inadvertently create new 
social problems while trying to solve existing ones. For 
example, complex challenges exist within clinical set-
tings to achieve optimum institutional disclosure pro-
cesses of HIV-positive test results to clients with newly 
acquired HIV infection. Budgetary constraints have cre-
ated incentives for policymakers to devise more efficient 
mechanisms to deliver HIV test results while ensuring 
that a higher proportion of patients receive their results. 
Evaluation of test-result provision practices was not an a 
priori study objective for this research, but instead 
revealed itself inductively as a salient theme across base-
line interviews, and speaks to an evolving landscape of 
these practices in British Columbia.
Although we noted the opportunities of interviewing 
men who received HIV test results very soon after acquir-
ing their infections, it is possible that many of our insights 
might resonate for other gay men diagnosed with HIV, 
irrespective of the stage of infection. The generalizability 
of these study findings is limited by our focused data 
from mostly gay men from six clinical sites in British 
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Columbia, Canada. Research with non-gay-identified 
men, as well as men outside of these clinic sites (e.g., in 
rural or remote areas of British Columbia), would be of 
benefit. In addition, recall bias could have impacted on 
the validity of the narratives we captured, because men 
were interviewed at different periods of time following 
their diagnoses. That being said, it is important to note 
that the majority of these interviews were conducted in a 
relatively proximate time period to infection and diagno-
sis; this is an important strength of these baseline qualita-
tive data.
We do not have access to men’s experiences beyond 
their detailed narrative accounts of diagnosis. As such, 
this analysis might benefit from future research that 
accounts for provider narratives of implementing new 
testing technologies. Complementary institutional ethno-
graphic research (Grace, 2013b; Smith, 2006) on the 
everyday actualities of conducting work in clinical envi-
ronments would provide added insight into the techno-
logically mediated process at play in these diagnostic 
settings. Nevertheless, we believe that the HIV diagnosis 
experiences shared by participants provide tremendous 
insight regarding the need to consider how diagnostic 
technologies are used and read in clinical practice amid a 
landscape of other communicative and biomedical 
technologies.
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Notes
1. NAAT tests detect the presence of viral ribonucleic 
acid (RNA) and result in a shortened window period of 
between 10 and 15 days, compared to most standard test-
ing approaches that use third-generation enzyme immuno-
assays (EIA) that have window periods of between 20 and 
30 days (Branson & Stekler, 2012).
2. Additional information is available on the Web site of 
the CIHR Team in the Study of Acute HIV Infection in 
Gay Men: www.acutehivstudy.com. Also see Gilbert et al. 
(2013) and Grace et al. (2014) for related publications.
3. Although any man who met the additional inclusion cri-
teria and identified as a man who had sex with men (e.g., 
could identify as gay, bisexual, queer, trans, straight, two-
spirit) was eligible for participation, only gay (n = 24) and 
bisexual (n = 1) men enrolled in the study. We use the word 
gay to describe the sample overall, given the salience of 
this concept for most participants and the highly problem-
atic nature of the term men who have sex with men (MSM) 
(Young & Meyer, 2005).
4. Information on this campaign is available at Health 
Initiative for Men’s Web site: www.checkhimout.ca/
hottest/.
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